Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical immunotherapy in pancreatic cancer
Xiaorong Ye, Yue Yu, Xiaohu Zheng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 4
Open Access | Times Cited: 14

Showing 14 citing articles:

Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 18
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy
Yishen Tian, Jingxuan Li, Na Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101545-101545
Open Access | Times Cited: 2
It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
Christin Knickmeier, Gaetan Aime Noubissi Nzeteu, Bernhard F. Gibbs, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy
Moon Nyeo Park, Jinwon Choi, Md. Maharub Hossain Fahim, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 7
Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines
Nawal Amhis, Julie Carignan, Lee‐Hwa Tai
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200825-200825
Open Access | Times Cited: 4
Spatial distribution and activation changes of T cells in pancreatic tumors according to KRAS mutation subtype
Ji Hye Jeong, Dakyum Shin, Sang‐Yeob Kim, et al.
Cancer Letters (2025), pp. 217641-217641
Open Access
Increased Herpesvirus Entry Mediator Expression on Circulating Monocytes and Subsets Predicts Poor Outcomes in Pancreatic Ductal Adenocarcinoma Patients
Isabelle Kuchenreuther, Finn-Niklas Clausen, Johanne Mazurie, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2875-2875
Open Access
Development of an alkaliptosis-related lncRNA risk model and immunotherapy target analysis in lung adenocarcinoma
Xiang Xiong, Wenzhao Liu, Chun‐Hsu Yao
Frontiers in Genetics (2025) Vol. 16
Open Access
Raman spectroscopy based diagnosis of pancreatic ductal adenocarcinoma
Gianmarco Lazzini, Raffele Gaeta, Luca Emanuele Pollina, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advancements in the Surgical Management of Pancreatic Masses: A Comprehensive Review
Cara Mohammed, P. S, Hugh Kolomar, et al.
Surgical Oncology Insight (2025), pp. 100147-100147
Open Access
Correlation between inflammatory cytokines and the likelihood of developing multiple types of digestive system cancers: A Mendelian randomization study
S. Chen, Bin Zhang, Song Wang, et al.
Cytokine (2024) Vol. 183, pp. 156735-156735
Open Access | Times Cited: 3
Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer
Ying Zhou, Yunxiao Ma, Jingdan Sheng, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 2
Oncolytic vaccinia virus armed with 4–1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1/PD-L1 blockade in a pancreatic cancer model
Yushi Ju, Feiyu Dai, Yirong Wang, et al.
Translational Oncology (2024) Vol. 50, pp. 102151-102151
Closed Access | Times Cited: 1
Near-infrared photoimmunotherapy as a complementary modality to in situ vaccine in a preclinical pancreatic cancer model
Hiroaki Yaku, Ken Takahashi, Hirokazu Okada, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 737, pp. 150534-150534
Open Access
Page 1

Scroll to top